Medtronic posted a strong profit for Q3 of fiscal year 2025, though shares were down as its cardiac ablation product success ...
MDT delivers strong earnings in the fiscal 2025 third quarter, with significant improvements in both gross and operating ...
Third-quarter results for Medtronic (NYSE:MDT) included a timeline for a planned label expansion for its automated insulin ...
Medtronic's stock has been static, not delivering any gains for investors. Click here to find out why MDT stock is a Buy.
Medtronic beat Wall Street estimates for third-quarter profit on Tuesday, partly helped by demand for its diabetes devices, ...
Investor's Business Daily on MSN5h
Why Medtronic Just Undercut Its Buy Zone With A 7% DropMedtronic stock skidded Tuesday after the medtech giant missed sales expectations, though profit came in well ahead of forecasts.
With the Food and Drug Administration now allowing the over-the-counter purchase of continuous glucose monitors (CGMs)—small ...
The global cardiac assist devices market share is poised to surpass USD 1.37 billion by 2023, surging at a remarkable CAGR of ...
Illustrates how companies can implement the Ten Principles of the UN Global Compact throughout their supply chains and integrate sustainability into procurement strategies. In 2015, the guide was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback